Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

RxSight, Inc. - Common Stock (NQ:RXST)

14.06 +1.00 (+7.66%)
Streaming Delayed Price Updated: 9:48 AM EDT, May 12, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about RxSight, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
RxSight's Earnings: A Preview
Via Benzinga
RxSight, Inc. to Report Second Quarter Financial Results on August 7, 2023
From RxSight, Inc.
Via GlobeNewswire
RxSight Is A Potential Acquisition Target: Analyst Highlights How LAL Revenue Mix Could Drive Share Price To $45+
Needham analyst David Saxon reiterated a Buy rating on RxSight, Inc. (NASDAQ: RXST),  
Via Benzinga
The Latest Analyst Ratings for RxSight
Via Benzinga
RxSight, Inc. Reports First Quarter 2023 Financial Results
From RxSight, Inc.
Via GlobeNewswire
Analyst Expectations for RxSight's Future
Via Benzinga
Looking Into RxSight's Return On Capital Employed
Via Benzinga
5 Analysts Have This to Say About RxSight
Via Benzinga
Earnings Preview: RxSight
Via Benzinga
RxSight, Inc. to Present at the Bank of America Healthcare Conference
From RxSight, Inc.
Via GlobeNewswire
RxSight, Inc. to Report First Quarter Financial Results on May 9, 2023
From RxSight, Inc.
Via GlobeNewswire
Multiple Surgeon Presentations to Highlight RxSight® Light Adjustable Lens System at Upcoming American Society of Cataract and Refractive Surgery Annual Meeting
From RxSight, Inc.
Via GlobeNewswire
Why RxSight Shares Are Plummeting
RxSight Inc (NASDAQ: RXST) shares are trading lower by 9.22% to $12.50 Wednesday morning after the company announced pricing of a public offering of common stock. What Else? 
Via Benzinga
RxSight Earnings Perspective: Return On Capital Employed
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 13, 2023
Via Benzinga
RxSight, Inc. to Present at the Needham Healthcare Conference
From RxSight, Inc.
Via GlobeNewswire
RxSight, Inc. Reports Fourth Quarter and Full Year 2022 Financial Results
From RxSight, Inc.
Via GlobeNewswire
RxSight, Inc. to Present at the Oppenheimer Healthcare Conference
From RxSight, Inc.
Via GlobeNewswire
RxSight, Inc. to Report Fourth Quarter and Fiscal Year 2022 Financial Results on March 6, 2023
From RxSight, Inc.
Via GlobeNewswire
RxSight, Inc. Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares and Closing of its Public Offering of Common Stock
From RxSight, Inc.
Via GlobeNewswire
$6M Bet On RxSight? Check Out These 3 Stocks Insiders Are Buying
Although US stocks closed higher on Monday, there were a few notable insider trades. 
Via Benzinga
Alphabet, Capri Holdings, Paycom Software And Other Big Stocks Moving Lower On Wednesday
U.S. stocks traded lower, with the Dow Jones dropping around 75 points on Wednesday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
RxSight, Inc. Announces Pricing of Public Offering of Common Stock
From RxSight, Inc.
Via GlobeNewswire
RxSight, Inc. Announces Proposed Public Offering of Common Stock
From RxSight, Inc.
Via GlobeNewswire
RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full Year 2022 Financial and Operational Results
From RxSight, Inc.
Via GlobeNewswire
RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference
From RxSight, Inc.
Via GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For December 12, 2022
Via Benzinga
RxSight, Inc. Reports Third Quarter 2022 Financial Results
From RxSight, Inc.
Via GlobeNewswire
Earnings Scheduled For November 7, 2022
Companies Reporting Before The Bell • NAPCO Security Techs (NASDAQ:NSSC) is expected to report quarterly earnings at $0.13 per share on revenue of $36.34 million. 
Via Benzinga
Earnings Outlook For RxSight
RxSight (NASDAQ:RXST) is set to give its latest quarterly earnings report on Monday, 2022-11-07. Here's what investors need to know before the announcement. Analysts estimate that RxSight will report... 
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.